Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-008886
Filing Date
2023-03-17
Accepted
2023-03-17 16:43:47
Documents
1
Period of Report
2023-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11123
  Complete submission text file 0000899243-23-008886.txt   12593
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

EIN.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4611 UNIVERSITY DR 4 UNIVERSITY PLACE DURHAM NC 27707
Business Address
WELCH DANIEL G (Reporting) CIK: 0001206199 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 23743303